TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Johnson& Johnson Pharmaceutical Research& Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of human integrin alpha-4-beta-7-mediated K562 cell adhesion to immobilized MAdCAM1More data for this Ligand-Target Pair
![](/img/powered_by_small.gif)